Amino acid chelates for reducing oxidative stress
OwnerScott L. Crain, Robert T. Coffeyinventors
Life of this patent
Estimating the term…
Abstract
Provided herein are formulations and methods useful in the treatment of diseases and disorders in livestock due to oxidative stress. The formulations include metal amino acid chelates.
Claims68
A formulation for reducing oxidative stress in a mammal comprising:
- one or more components selected from zinc amino acid chelate, copper amino acid chelate, manganese amino acid chelate, magnesium amino acid chelate, and potassium amino acid complex.
The formulation of any one of the preceding claims, wherein the formulation is formulated for oral delivery.
The formulation of any one of the preceding claims, wherein the formulation is a powder.
The formulation of any one of the preceding claims, wherein zinc amino acid chelate is in the range of about 1% to about 30% by weight.
The formulation of any one of the preceding claims, wherein copper amino acid chelate is in the range of about 1% to about 30% by weight.
The formulation of any one of the preceding claims, wherein manganese amino acid chelate is in the range of about 0.5% to about 25% by weight.
The formulation of any one of the preceding claims, wherein magnesium amino acid chelate is in the range of about 1% to about 30% by weight.
The formulation of any one of the preceding claims, wherein potassium amino acid complex is in the range of about 1% to about 30% by weight.
A formulation for preventing and/or treating lameness in a mammal comprising:
- one or more amino acid chelate(s) selected from one or more components selected from zinc amino acid chelate, copper amino acid chelate, manganese amino acid chelate, magnesium amino acid chelate, and potassium amino acid complex.
The formulation of any of the preceding claims, further comprising one or more of N-acetyl-L-cysteine, glycine, glutamic acid, and cysteine.
A method for reducing oxidative stress in a mammal comprising administering a formulation comprising one or more components selected from zinc amino acid chelate, copper amino acid chelate, manganese amino acid chelate, magnesium amino acid chelate, and potassium amino acid complex.
A method for preventing and/or treating cattle fatigue syndrome in a mammal comprising administering a formulation comprising one or more components selected from zinc amino acid chelate, copper amino acid chelate, manganese amino acid chelate, magnesium amino acid chelate, and potassium amino acid complex.
A method for preventing and/or treating a disease caused by oxidative stress in a mammal comprising administering a formulation comprising one or more components selected from zinc amino acid chelate, copper amino acid chelate, manganese amino acid chelate, magnesium amino acid chelate, and potassium amino acid complex.
A method for improving mobility in fed cattle, the method comprising administering to the cattle a formulation comprising zinc amino acid chelate, copper amino acid chelate, manganese chelate, magnesium amino acid chelate, and potassium amino acid complex, daily for about 1 to about 150 days thereby resulting in increased mobility.
A method for reducing pain and/or oxidative stress in a population of animals, the method comprising:
- (i) administering to the population a formulation comprising zinc amino acid chelate, copper amino acid chelate, manganese chelate, magnesium amino acid chelate, and potassium amino acid complex, daily for about 1 to about 150 days;
- (ii) obtaining a sample from a subset of the animal population;
- and
- (iii) measuring in the sample one or more biomarkers of pain and/or oxidative stress wherein reduction in the one or more biomarkers results in a reduction of pain and/or oxidative stress.
Dependencies are inferred from the claim text.